UPDATE ON WEIGHT MANAGEMENT MEDICATION (Mounjaro) June 2025

As you may know, the NHS has announced that General Practice is now able to prescribe Tirzepatide (Mounjaro) for eligible people to help with weight management.

Please note that initially, eligibility for Mounjaro will be for people at highest clinical risk, based on national criteria.  These include a body mass index of 40 or more – PLUS at least four of the following health problems: high blood pressure; high cholesterol or fat levels in your blood; sleep apnoea; heart disease; and type 2 diabetes.

We will be proactively contacting eligible patients in the coming weeks to offer assessment for Mounjaro.

Information about this, including frequently asked questions, can be found on the North East and North Cumbria's Integrated Care Board's website at:

https://www.northeastnorthcumbria.nhs.uk/here-to-help-you/health-advice-and-support/weight-loss-drugs-information-for-patients

Please do not contact us (despite the advice on the NHS website) unless you consider yourself to be eligible based on the advertised criteria.

Further information about achieving a healthy weight is available here: https://www.nhs.uk/live-well/healthy-weight/

Published: Jun 17, 2025